Dr. Sotiris Masmanidis' lab at UCLA focuses on understanding how the brain's timing mechanisms are intertwined with the reward learning process, specifically through the study of dopamine neurons in the midbrain. The lab employs a combination of experimental techniques and computational modeling to investigate how these neural circuits learn to predict when rewards are expected, which is important for behaviors like learning and decision-making. This research could shed light on fundamental processes that, when disrupted, can lead to issues like addiction.

Dr. Hanna Mikkola's lab at UCLA studies how different forms of a protein called MLLT3 influence the growth and behavior of human hematopoietic stem cells (HSCs), which are crucial for blood formation. They aim to understand how these protein variants can help improve the self-renewal and differentiation of HSCs, which is important for potential therapies for blood diseases. This research could lead to better ways to generate stem cells for treatments.

Dr. David W. Walker's lab at UCLA focuses on understanding how changes in mitochondria contribute to the aging process and Alzheimer's disease. By studying how mitochondrial DNA is released into cells and triggers inflammation, the lab aims to uncover potential therapeutic strategies to combat age-related diseases. Utilizing Drosophila models, the research explores the links between mitochondrial function, immune responses, and longevity.

Dr. Arumugaswami's lab focuses on understanding monkeypox virus, particularly how it affects the eyes, leading to serious conditions like keratitis and corneal opacity. They explore both the viral mechanisms that enable the monkeypox virus to evade the immune system and the host responses that occur during infection. The ultimate goal is to find new potential therapies to treat ocular complications caused by this virus.

Dr. Caius Gabriel Radu's lab is focused on creating innovative mRNA vaccines aimed at improving cancer treatment, specifically for pancreatic cancer. The research explores how these vaccines can enhance therapies that involve transferring immune cells to fight tumors. By studying these vaccines in complex mouse models that mimic human immune systems, the lab aims to address challenges in current cancer therapies and develop effective treatments for patients with difficult-to-treat cancers.

Dr. April Pyle's lab at UCLA focuses on understanding how skeletal muscle cells develop from human pluripotent stem cells (hPSCs). They study the differences between these stem cells and adult muscle stem cells to improve their ability to generate healthier muscle cells for research and potential therapies. By investigating and enhancing how these cells behave in a lab setting, they aim to create better models for muscle diseases and advance regenerative medicine.

Dr. Timothy E. O'Sullivan's lab focuses on understanding how human natural killer (NK) cells function, especially in the context of viral infections like cytomegalovirus, which is particularly dangerous for newborns and immunocompromised individuals. By investigating the transcriptional regulators like MEF2C, the lab aims to develop strategies to enhance NK cell activity, potentially leading to new treatments for patients who are at high risk for these infections. This research combines molecular biology and immunology to improve health outcomes.

Dr. Volker Hartenstein's lab at UCLA studies how brain circuits develop and control behavior, using fruit flies (Drosophila) as a model organism. The team focuses on a specific brain circuit involved in navigation, investigating how neurons are connected and how they function to help flies find food and avoid danger. By mapping these connections and employing genetic tools, they aim to understand both larval and adult brain functions and their adaptations during development.

Dr. Rhonda Voskuhl's lab focuses on understanding the differences in neurodegeneration in multiple sclerosis (MS) based on individual patient characteristics like sex, age, and specific disabilities. Their research aims to develop targeted treatments that repair disabilities resulting from MS by studying how various cell types in the central nervous system behave in different regions of the brain. By utilizing a range of experimental techniques, the lab assesses how these factors contribute to MS progression and therapeutic outcomes.

Dr. Daniel Geschwind's lab at UCLA focuses on understanding the genetics behind neuropsychiatric and neurodevelopmental disorders. The lab uses advanced stem cell technologies and high-throughput phenotyping to study how various genes affect brain development and function, aiming to uncover the biological mechanisms that contribute to disorder risk. To achieve this, they develop models using human stem cells to analyze gene knockouts and their effects on neuronal behavior.

Dr. Heather Christofk's research lab at UCLA focuses on understanding how nutrients, particularly the amino acid asparagine, regulate cancer growth. The lab studies how renal cell carcinoma, a common kidney cancer, depends on asparagine for its survival and proliferation. Their work explores ways to target this dependency to improve treatment strategies, including the use of existing FDA-approved drugs like L-asparaginase and metformin.

Dr. Karen Reue's lab at UCLA focuses on understanding how genetic factors, particularly on the X chromosome, influence obesity and related cardiovascular disease risks in women. They explore how the Kdm5c gene affects fat storage and energy balance, especially during menopause, aiming to uncover how sex differences play a role in these health issues. Ultimately, this research seeks to inform better prevention strategies for obesity and cardiovascular disease in both genders.

Dr. Paivi Pajukanta's lab at UCLA focuses on understanding how obesity affects health, particularly in regards to cardiometabolic diseases like diabetes and liver disease. The lab conducts cutting-edge research using advanced techniques like single-cell RNA sequencing to uncover the genetic and environmental factors that influence these diseases. Their ultimate goal is to identify ways to prevent or delay the onset of these diseases, especially considering the differences between sexes in disease predisposition.

Dr. Kathrin Plath's lab focuses on understanding how gene expression is regulated on the X chromosomes during embryonic development and its crucial role in the placenta's function. They specifically study X chromosome dosage compensation mechanisms and how their disruption can lead to developmental issues in embryos. By using mouse models, the lab aims to uncover the underlying processes affecting the feto-maternal interface, ultimately providing insights into female-specific developmental disorders and placental health.

Dr. Kyung Hyun Sung's lab at UCLA focuses on improving the detection and diagnosis of aggressive prostate cancer, particularly among African American men who are disproportionately affected by this disease. Using advanced MRI techniques and innovative software tools, the lab aims to develop more accurate imaging models that account for racial differences in prostate cancer characteristics. The ultimate goal is to reduce disparities in prostate cancer diagnosis and treatment outcomes through enhanced imaging and analysis methods.

Dr. Frank Pajonk's lab at UCLA focuses on improving radiation therapy for patients with glioblastoma, a type of brain cancer. The research targets the unique properties of cancer stem cells that make tumors resistant to treatment, specifically looking for ways to promote the differentiation of these cells into non-cancerous types. By developing new compounds that can cross the blood-brain barrier, the lab aims to enhance the effectiveness of radiotherapy and ultimately improve patient outcomes.

Dr. Elaine F Reed's lab focuses on understanding the immune system's responses in organ transplant recipients, particularly how immunosuppressive therapies affect vaccine efficacy and transplant rejection. They are exploring the immune responses to SARS-CoV-2 vaccines in kidney transplant patients, investigating how specific treatment regimens influence immunity. Additionally, the lab examines the molecular mechanisms that lead to graft rejection and finds innovative ways to enhance transplant outcomes.

Dr. Jessica E Rexach's lab focuses on understanding the role of interneurons in Alzheimer’s disease and related dementias using innovative stem cell models. The lab creates assembloids derived from human induced pluripotent stem cells (iPSCs) to mimic the complex interactions between different types of brain cells, particularly how mutations in the tau protein affect cognitive decline. By studying how these cells work together, the lab aims to uncover potential pathways for developing new treatments and improving clinical trials.

Dario L Ringach's lab at UCLA focuses on understanding how neurons in the cortex become specialized for processing visual information and how they are organized into functional maps. They investigate how thalamic inputs influence cortical structure and function, specifically exploring the role of ON/OFF pathways from the retina in shaping our ability to perceive and respond to visual stimuli. This research is significant for understanding developmental brain disorders and enhancing our knowledge of cognitive processes.

At Dr. Dorthe Schaue's lab at UCLA, researchers focus on using a new imaging technique called autofluorescence to measure how much radiation exposure organisms have experienced. This research aims to develop a way to quickly assess radiation damage, which is crucial for making timely medical decisions during emergencies. By studying how cells respond to radiation at the molecular level, the lab hopes to create a tool that can predict acute health risks related to radiation and enhance safety protocols during radiological events.